Nanosuspensions as particulate drug formulations in therapy
Top Cited Papers
- 1 March 2001
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 47 (1), 3-19
- https://doi.org/10.1016/s0169-409x(00)00118-6
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Heavy metal contamination of nanosuspensions produced by high-pressure homogenisationInternational Journal of Pharmaceutics, 2000
- Atovaquone and proguanil hydrochloride followed by primaquine for treatment of Plasmodium vivax malaria in ThailandTransactions of the Royal Society of Tropical Medicine and Hygiene, 1999
- Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticlesJournal of Controlled Release, 1997
- Bioadhesion of solid oral dosage forms, why and how?European Journal of Pharmaceutics and Biopharmaceutics, 1997
- Identification of plasma proteins facilitated by enrichment on particulate surfaces: Analysis by two‐dimensional electrophoresis and N‐terminal microsequencingElectrophoresis, 1997
- Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogsInternational Journal of Pharmaceutics, 1995
- Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in ratsInternational Journal of Pharmaceutics, 1995
- Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresisElectrophoresis, 1993
- Particle Size Analysis of Latex Suspensions and Microemulsions by Photon Correlation SpectroscopyJournal of Pharmaceutical Sciences, 1984
- INTERACTION OF PHAGOCYTES WITH OTHER BLOOD CELLS AND WITH PATHOGENIC AND NONPATHOGENIC MICROBESAnnals of the New York Academy of Sciences, 1983